Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04868760
Status:
UNKNOWN
Last Update Posted:
2022-10-04
First Post:
2021-04-23
Brief Title:
A Study to Evaluate the Similarity in Pharmacokinetics and Safety of IBI310 and IpilimumabYERVOYin Adult Healthy Chinese Male Volunteers
Sponsor:
Innovent Biologics Suzhou Co Ltd
Organization:
Innovent Biologics Suzhou Co Ltd
Organization Data
Organization:
Innovent Biologics Suzhou Co Ltd
Class:
INDUSTRY
Study ID:
CIBI310G101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Innovent Biologics Suzhou Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None